Crossmark

Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application

Crossref DOI link: https://doi.org/10.1177/2168479013509382

Published Online: 2014-12-30

Published Print: 2014-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Archdeacon, Patrick

Grandinetti, Cheryl

Vega, José M.

Balderson, David

Kramer, Judith M.
License Information

Text and Data Mining valid from 2014-03-01
More Information

Article History

Received: 24 June 2013

Accepted: 25 September 2013

First Online: 30 December 2014